Aggressive Macroprolactinoma Refractory to Multiple Lines of Localized and Systemic Therapy. [PDF]
Konindala N, Paluri R, Darapu H.
europepmc +1 more source
Real-life data on pasireotide in monotherapy or combined in active Cushing's disease. [PDF]
Mondin A +6 more
europepmc +1 more source
Long-term primary pharmacotherapy of giant prolactinomas: A comparison of different cabergoline dosages. [PDF]
Václav H +11 more
europepmc +1 more source
Cabergoline (Dostinex) Effect on Weight Ovarian Function
Rawa Jaafar Kadhim Al Ameri
openalex +1 more source
Secondary Loss of Response to Dopamine Receptor Agonists in the Treatment of Macroprolactinoma. [PDF]
Alkundi A, Momoh R.
europepmc +1 more source
"Cabergoline, Levosimendan and Iabp: Treatment of Peripartum Cardiomyopathy"
Silvia Donfrancesco +50 more
openalex +1 more source
Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas? [PDF]
Agrawal N +11 more
europepmc +1 more source
Effect of cabergoline on the management of diabetes mellitus: a systematic review and meta-analysis. [PDF]
Khorasani S +5 more
europepmc +1 more source

